메뉴 건너뛰기




Volumn 77, Issue 3, 2011, Pages 430-434

Transcatheter aortic valve implantation by left subclavian access in the presence of a patent LIMA to LAD graft

Author keywords

corevalve; high risk surgical patients; percutaneous aortic valve replacement; subclavian access

Indexed keywords

HEART ENZYME; ILOPROST; INSULIN;

EID: 79951884370     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22417     Document Type: Article
Times cited : (10)

References (14)
  • 3
    • 33749634251 scopus 로고    scopus 로고
    • Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study
    • DOI 10.1161/CIRCULATIONAHA.106.639450, PII 0000301720061010000012
    • Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW,. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006; 114: 1616-1624. (Pubitemid 44547432)
    • (2006) Circulation , vol.114 , Issue.15 , pp. 1616-1624
    • Grube, E.1    Laborde, J.C.2    Gerckens, U.3    Felderhoff, T.4    Sauren, B.5    Buellesfeld, L.6    Mueller, R.7    Menichelli, M.8    Schmidt, T.9    Zickmann, B.10    Iversen, S.11    Stone, G.W.12
  • 5
    • 55849132881 scopus 로고    scopus 로고
    • Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval
    • Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW,. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
    • (2008) EuroIntervention , vol.4 , pp. 242-249
    • Piazza, N.1    Grube, E.2    Gerckens, U.3    Den Heijer, P.4    Linke, A.5    Luha, O.6    Ramondo, A.7    Ussia, G.8    Wenaweser, P.9    Windecker, S.10    Laborde, J.C.11    De Jaegere, P.12    Serruys, P.W.13
  • 6
    • 0037058854 scopus 로고    scopus 로고
    • Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description
    • DOI 10.1161/01.CIR.0000047200.36165.B8
    • Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB,. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008. (Pubitemid 35440280)
    • (2002) Circulation , vol.106 , Issue.24 , pp. 3006-3008
    • Cribier, A.1    Eltchaninoff, H.2    Bash, A.3    Borenstein, N.4    Tron, C.5    Bauer, F.6    Derumeaux, G.7    Anselme, F.8    Laborde, F.9    Leon, M.B.10
  • 11
    • 70350462146 scopus 로고    scopus 로고
    • When operable patients become inoperable: Conversion of a surgical aortic valve replacement into transcatheter aortic valve implantation
    • Olsen LK, Arendrup H, Engstrøm T, Søndergaard L,. When operable patients become inoperable: Conversion of a surgical aortic valve replacement into transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg 2009; 9: 837-839.
    • (2009) Interact Cardiovasc Thorac Surg , vol.9 , pp. 837-839
    • Olsen, L.K.1    Arendrup, H.2    Engstrøm, T.3    Søndergaard, L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.